echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Leading foreign pharmaceutical enterprises in large scale bidding and bid abandonment in many places

    Leading foreign pharmaceutical enterprises in large scale bidding and bid abandonment in many places

    • Last Update: 2015-04-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: China Radio Network April 20, 2015 according to the voice of China, CCTV news, during this year's drug bidding in Zhejiang Province, there was a phenomenon that drug companies abandoned their bids in a large scale, especially foreign drug companies, with the overall average rate of bid abandonment reaching 60.5%, the highest rate of 92.3% Zhejiang provincial drug purchase center has previously released a news about "collecting the lowest price of relevant products in China", which makes some pharmaceutical enterprises, especially foreign enterprises, who accept the price drop, feel "the whole person is not good" again A pharmaceutical enterprise involved in the quotation disclosed to reporters that the purchase requirements of Zhejiang pharmaceutical enterprises are the lowest price in the country If they don't accept it, they can only leave here If the price confirmed by the previous reduction is even lower than the national lowest price, the lowest price shall be adopted This also means that in the second drug bidding in Zhejiang Province, some drugs will generate new national lowest prices This leads to the phenomenon that the bid abandonment rate reaches 60.5% The high price of drugs has become a hot topic this year Now more than 90% of drugs have a very large price reduction space, and many enterprises have cut the price by 50% There is no such problem Others say that there is a considerable space for drug prices to be reduced, and that drug companies and hospitals are likely to lower their drug prices by themselves It is imperative to reduce the price of drugs When drug companies feel that they are losing money, most of them abandon the target A well-known foreign company executive told reporters that their company had held such a seminar on whether to abandon the bid, which was very controversial The boss thought the profit was not big, so he abandoned the bid temporarily In Hunan, Zhejiang, and other places, there have been large-scale bid abandonment in drug bidding What are the difficulties for drug companies? Is this kind of phenomenon a coincidence or a trend? In January of this year, Hunan Pharmaceutical bidding carried out a price reduction of less than 10% and more than 50% for 26440 product specifications within the scope, which caused foreign pharmaceutical enterprises to abandon their bids At the same time, in the process of drug bidding in Hunan Province, Zhejiang Shaoxing No.3 class a hospital made price adjustment, and listed 14 foreign drugs with higher price into the scope of suspension or restriction In fact, since last year, there has been a downward trend in drug bidding prices In 2014, local health departments generally lowered the price of drugs within the scope by about 25% in bidding At that time, most pharmaceutical companies analyzed that after the sharp drop, the drug price could be stable for a period of time But just a year later, prices fell sharply again In the face of such a decline, foreign pharmaceutical companies have abandoned the bid There are 15 varieties of Novo Nordisk, 13 varieties of Squibb, 34 varieties of Pfizer and so on In addition to Hunan Province, Zhejiang Province and Liaoning Province have also heard the wind of bidding price reduction For foreign funded pharmaceutical companies, it's hard to do more than that In 2015, the policy that the original research drug will cancel the independent pricing may be introduced, which will be a fatal blow to foreign funded pharmaceutical companies The so-called "original research drug" refers to the imported drug that has passed the patent period For many years, China has set separate pricing rules for the original research drugs The price difference between these drugs and domestic generic drugs is several times, many times In 2015, this rule may be changed to market pricing mechanism In addition to the substantial price reduction for foreign-funded enterprises, the drug bidding in Hunan Province has also made such a significant reduction for local enterprises, with a maximum reduction of 50% Compared with foreign pharmaceutical enterprises, local enterprises have been used to running in low profit rate for many years, so even in the face of such a huge price reduction, there are few enterprises abandoning the target So this time, the market that foreign capital gives up is a good opportunity for local enterprises to expand the market According to a statistics of the pharmaceutical industry, the proportion of foreign drugs in the top three and above hospitals has reached about 70% Since last year, the proportion of foreign drugs has been reduced to about 60% with the increase of the number of foreign bids abandoned and local enterprises winning the bid This time, with the implementation of the policy of "no serious illness out of the county" called for by all parts of the country, most of the patients in the second and third tier cities were left to see doctors in the county-level cities As the main market of domestic pharmaceutical enterprises, the county-level cities have accounted for 70% - 80% of such a share.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.